Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology

Molecular Genetics & Genomic Medicine

Shuo Zhang¹  Yanping Xi¹  Caixia Lei¹  Min Xiao¹  Yueping Zhang¹  Xiaoxi Sun¹  Wenbi Zhang¹  Junping Wu¹  Guangquan Chen² 

[1] Shanghai Ji Ai Genetics & IVF Institute Obstetrics and Gynecology Hospital of Fudan University Shanghai China;WuXi NextCODE Genomics (Shanghai) Co., Ltd. Shanghai China;

关键词: assisted reproductive technology;    expanded carrier screening;    Han Chinese ethnicity;    preimplantation genetic testing;    recessive disease;   

DOI  :  10.1002/mgg3.1340

来源: DOAJ

【 摘 要 】

Abstract Background Expanded carrier screening (ECS) has emerged as an effective approach to identify at‐risk couples (ARCs)—before they initiate attempts at reproduction—who possess a high probability of having a child affected by severe recessive diseases. The objective of this study was to evaluate the clinical utility of ECS in Chinese patients seeking the help of assisted reproductive technology (ART). Methods An ECS test, which covers 201 genes implicated in 135 recessive (autosomal or X‐linked) diseases, was routinely offered to all ART patients in a single genetics and in vitro fertilization clinic. Additional options for preimplantation or prenatal genetic diagnosis were discussed and offered to all ARCs. All ECS results were aggregated and the clinical decisions of the ARCs were surveyed. Results A total of 2,923 ART patients, representing 1,462 couples, were screened. Overall, 46.73% of the individuals were found to be the carriers for at least 1 of the 135 diseases. Of the tested couples, 2.26% (n = 33) were identified as ARCs. As of the completion of this study, 21 (63.6%) ARCs have decided to avert an affected pregnancy with the help of preimplantation genetic testing for monogenetic conditions. The cumulative carrier rate of the 187 autosomal recessive genes in the ECS panel for the 2,836 Han Chinese individuals without a family history was estimated to be 45.91%. The estimated at‐risk couple rate indicates that the screening for only the top 31 genes with gene carrier rates >0.5% would identify more than 94% of the ARCs identified by screening all 187 genes. Conclusion Our study demonstrates that ESC yields a significant clinical value for ART patients in China. In addition, by estimating the yields of the ECS panel, we identify genes that are appropriate for screening the Han population.

【 授权许可】

Unknown